The data on Pfizer's GLP-1 offer early evidence that the injection can be administered less frequently than existing drugs ...

Researchers are applying insights into the genetic variations and physiology of obesity to apply tailored interventions to ...

A long-acting shot Pfizer got through a buyout of Metsera appeared “slightly inferior” to Lilly’s market-leading Zepbound in ...

Researchers have quantified the role of obesity in common long-term conditions, showing for the first time the effect of ...

Pfizer made one thing clear this week: It's officially back in the obesity race.

Doctors, patients and researchers are at the very beginning of understanding how the new class of obesity drugs interact with ...

Over the next decade, obesity rates across the nation could surge to close to half of U.S. adults, a new study published in ...

By Mrinalika Roy and Siddhi Mahatole Feb 3 (Reuters) - Shares of obesity drugmakers and developers slid on Tuesday, after ...

As doctors learn why GLP-1s don't work for about 50% of people, they are also learning more about the complex drivers of ...

Researchers reviewed the body mass index of over 11 million Americans.

Obesity is contributing to a record proportion of deaths among pregnant women, the Royal College of Physicians has warned.

Sen. Ana Maria Rodriguez and Rep. Susan L. Valdés were joined Thursday by Dr. Joey Jarrard of Tallahassee Memorial Healthcare ...